TORONTO, Aug. 24,
2022 /CNW/ - Pathway Health Corp. (TSXV: PHC)
(Frankfurt: KL1) ("Pathway" or the "Company") is pleased
to announce the appointment of Mr. Mark
Goldhar to the board of directors of the Company. Mr.
Goldhar will also join the Audit and the Compensation and
Governance Committees.
Mr. Goldhar has co-founded 12 companies, 4 of which were exited
to public companies or strategic acquirers, valued at over
$80M. Mark has raised over
$50M in debt and equity financing for
several companies. He served as a founding shareholder and CFO for
two pharmaceutical cannabis companies, both of which resulted in
exits through public companies. He also cofounded three companies
in the psychedelics space, serving as CFO to one that exited
through a public company. He continues to serve on the board of one
and as financial advisor to the other. Mr. Goldhar is a Chartered
Professional Accountant with over 15 years of industry
experience.
"Mark's experience in raising capital, providing strategic
advice for entrepreneurial companies in the finance, digital media
and cannabis space speaks for itself. His perspective on our growth
and strategic initiatives will be immensely impactful," said
Ken Yoon, Chief Executive Officer of
Pathway.
Neither the Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the Exchange) accepts
responsibility for the adequacy or accuracy of this Press Release.
The TSX Venture Exchange Inc. has in no way passed upon the merits
of the proposed transaction and has neither approved nor
disapproved the contents of this press release.
SOURCE Pathway Health Corp.